Cargando…
Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer
Metabolic reprogramming plays a critical role in colorectal cancer (CRC). It contributes to CRC by shaping metabolic phenotypes and causing uncontrolled proliferation of CRC cells. Glucose metabolic reprogramming is common in carcinogenesis and cancer progression. Growing evidence has implicated the...
Autores principales: | Yan, Shushan, Wang, Shufeng, Wang, Xinyi, Dai, Wenqing, Chu, Jinjin, Cheng, Min, Guo, Zhiliang, Xu, Donghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376248/ https://www.ncbi.nlm.nih.gov/pubmed/35978828 http://dx.doi.org/10.3389/fonc.2022.954329 |
Ejemplares similares
-
Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
por: Chu, Jinjin, et al.
Publicado: (2022) -
The Emerging Landscape of Long Non-Coding RNAs in Colorectal Cancer Metastasis
por: Liao, Zhiming, et al.
Publicado: (2021) -
Non-Coding RNAs Operate in the Crosstalk Between Cancer Metabolic Reprogramming and Metastasis
por: Li, Ziyi, et al.
Publicado: (2020) -
Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2019) -
Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)